Nel ASA's Aberdeen Blueprint Takes Shape as October Earnings Loom

Nel ASA's Hydrasun framework covers balance-of-plant work in Aberdeen, backed by Scotland's Just Transition Fund, but no order value was disclosed.

Nel ASA has finally put some flesh on the bones of its European expansion plan. The Norwegian hydrogen specialist's framework agreement with Scotland's Hydrasun, unveiled last Friday, is beginning to look less like a press release and more like an actual industrial footprint — even if the company remains conspicuously tight-lipped about the money involved.

Under the arrangement, Hydrasun will handle procurement, integration and manufacturing of balance-of-plant systems for Nel's MC-Series PEM electrolyser platform. Stack production stays where it is: Wallingford, Connecticut. The European assembly and integration capacity being built out is anchored in Aberdeen, Scotland.

A dozen jobs, a government fund, and no price tag

Reuters, citing the joint company statement, reported that the Aberdeen site upgrade is being backed by Scotland's Just Transition Fund. The project could generate as many as twelve new positions while safeguarding eleven existing ones — at Hydrasun, not at Nel. That headcount may look modest, but it is the most tangible yardstick yet for the scale of the investment, a detail absent from the original announcement. The involvement of a state-backed fund also signals that Edinburgh is actively courting hydrogen infrastructure build-out, lending the project a degree of political tailwind.

What the communiqué still does not say is how much any of this is worth. No order value, no euro or dollar figure, no volume guidance. Media coverage framed the deal as a strategic step to widen European integration capacity, yet no separate ad-hoc disclosure with hard numbers followed. For investors, that means strategic substance without a blueprint for revenue impact. Whether the framework agreement actually translates into meaningful orders for Nel will only become clear over the coming quarters.

The market's muted verdict

The stock has barely acknowledged the extra detail. Nel shares closed Friday at EUR 0.1950, up 0.4% on the day. Zoom out, though, and the picture darkens: a 5.8% decline over the past 30 days, a 47% gap to the 52-week high of EUR 0.3655, and a 200-day moving average sitting 8.5% above the current price. The medium-term trend has not turned.

Since the start of the year, however, the stock is still up 3.3% — evidence that the title has steadied after a soft summer. The RSI reads 46.8, neither overbought nor oversold, placing the shares in a stretch of relative calm.

October 21 is the real test

That calm will be tested soon. On October 21, 2026, Nel reports third-quarter figures, and the focus will fall squarely on whether the European strategic pivot is already showing up in the order book. The division of labour — stacks in the US, assembly and integration in Europe — is designed to let Nel respond faster to local demand without sinking more capital into new plants. Whether that translates into signed contracts or remains a structural gesture is the question the quarterly report must answer.

Until then, the Hydrasun deal stands as the most concrete operational development investors have to work with. How management communicates progress on the European build-out ahead of the numbers may matter as much as the numbers themselves.